Correlation Of Psychosomatic Factors And Personality Traits With The Severity Of Hidradenitis Suppurativa

Correlation Of Psychosomatic Factors And Personality Traits With The Severity Of Hidradenitis Suppurativa

Authors

  • Konstantinos Kontoangelos 1st Department of Psychiatry, Eginition Hospital, Medical School National & Kapodistrian University of Athens, Athens, Greece
  • Foteini Dionysia Foulou 1st Department of Psychiatry, Eginition Hospital, Medical School National & Kapodistrian University of Athens, Greece
  • Sofia Tsiori 1st Department of Psychiatry, Eginition Hospital, Medical School National & Kapodistrian University of Athens, Greece
  • Charalabos Papageorgiou University Mental Health Neurosciences and Precision Medicine Research Institute “Costas Stefanis”, Greece
  • Alexander Stratigos 1st Dermatology Department, Andreas Syggros Hospital for Skin Diseases, National & Kapodistrian University of Athens, Greece
  • Aikaterini I Liakou 1st Dermatology Department, Andreas Syggros Hospital for Skin Diseases, National & Kapodistrian University of Athens, Greece

Keywords:

factitious disorder, depression, psychosomatic, pain, psychodermatology

Abstract

Introduction: Hidradenitis suppurativa is a disease with a decisive burden on sufferers, both physical and psychological. It was expected that the more intense the severity of symptoms the patients experienced, the greater the correlation with the psychosomatic manifestations would be.

Objectives: The present study aimed to explore the correlation between hidradenitis suppurativa and the psychosomatic burden, the personality, and the demographic characteristics of the participants.

Methods: The participants were 90 outpatients of the hospital, aged 18 to 65, who had been diagnosed with hidradenitis and were sufficiently proficient in Greek. The psychometric instruments administered were the Symptom Checklist-90 (SCL90), the Beck Depression Inventory (BDI), the Eysenck Personality Questionnaire (EPQ), the short-form McGill Pain Questionnaire (SF-MPQ), the Hurley and refined Hurley classifications, the International Hidradenitis Suppurativa Severity Scoring System  (IHS4), and a short demographic questionnaire. All statistical analyses were performed using the SPSS-28 statistical package.

Results: According to statistical analyses, there was no statistically significant relationship between disease severity, psychosomatic burden, and personality. However, there were statistically significant associations with demographic factors, such as being female or not being in a relationship, the patient’s body mass index, the locus of the skin lesion, a history of hospitalization, comorbidities, psychiatric history, and pain with psychopathological manifestations and personality.

Conclusions: It is important that further research be conducted that will include more mental disorders besides anxiety and depression while at the same time excluding confounding factors for safer interpretation of the results.

References

Fabrazzo M, Cipolla S, Signoriello S, et al. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. J Eur Psychiatry. 2021 Nov 25;64(1):e71. DOI: 10.1192/j.eurpsy.2021.2249.

Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5), S19-S22. DOI: 10.1016/j.jaad.2015.07.054.

Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4), 539-561. DOI:10.1016/j.jaad.2008.11.911.

Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015; 29(2):371-376. DOI:10.1111/jdv.12567.

Sabat R, Jemec GB, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. DOI: 10.1038/s41572-020-0149-1.

Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4), 539-561. DOI:10.1016/j.jaad.2008.11.911.

Patel KR, Lee HH, Rastogi S, et al. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2020; 83(3): 737-744. DOI:10.1016/j.jaad.2019.11.068.

de Souza DF, Wartchow K, Hansen F, et al. Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43: 14-22. DOI:10.1016/j.pnpbp.2012.12.001.

Van der Zee HH, de Ruiter L, Van Den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β and IL‐10 in hidradenitis suppurativa skin: a rationale for targeting TNF‐α and IL‐1β. Br J Dermatol. 2011;164(6), 1292-1298. DOI:10.1111/j.1365-2133.2011.10254.x

Kohorst JJ, Kimball AB, Davis MD. Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol. 2015; 73(5), S27-S35. DOI:10.1016/j.jaad.2015.07.055.

König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999; 198(3), 261-264. DOI:10.1159/000018126.

Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuropsychopharmacol Biol Psychiatry 2014; 52: 79-85. DOI:10.1016/j.pnpbp.2013.07.010.

Caccavale S, Tancredi V, Boccellino MP, Babino G, Fulgione E, Argenziano G. Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis. Life. 2023; 13(1), 189. DOI:10.3390/life13010189.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). 2013. DOI:10.1176/appi.books.9780890425596.

Chou YJ, Tai YH, Dai YX, et al. Obsessive–compulsive disorder and the associated risk of autoimmune skin diseases: a nationwide population-based cohort study. CNS Spectr. 2023; 28(2), 157-163. DOI:10.1017/S1092852921000973.

Phan K, Huo Y R, Smith SD. Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis. Ann Transl Med. 2020; 8(13):821. DOI: 10.21037/atm-20-1028.

Krajewski PK, Matusiak L, Von Stebut E, et al. Pain in hidradenitis suppurativa: a cross-sectional study of 1,795 patients. Acta Derm Venereol. 2021;101(1). DOI:10.2340/00015555-3724.

Matusiak Ł, Szczęch J, Kaaz K, Lelonek E, Szepietowski JC. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol. 2018; 98(2), 191-194. DOI:10.2340/00015555-2815.

Puza CJ, Wolfe SA, Jaleel T. Pain management in patients with hidradenitis suppurativa requiring surgery. Dermatologic Surgery. 2019;45(10),1327-1330. DOI:10.1097/DSS.0000000000001693.

Bair M J, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of internal medicine. 2003;163(20),2433-2445. DOI:10.1001/archinte.163.20.2433.

Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595-605.

Donias, S.; Karastergiou, A.; Manos, N. Validation of the Symptom Checklist- 90-R in Greek Population. Psychiatriki. 1991, 2, 42–48. DOI: 10.5431/aramit0209.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571. DOI:10.1001/archpsyc.1961.01710120031004.

Eysenck HJ, Eysenck SBG. Manual of the EPQ (Personality Questionnaire) Hodder and Stoughton Educational; Hodder & Stoughton Educational: London, UK, 1975.

Dimitriou, E. EPQ Personality Questionnaire. Greek Validation in the Greek Population Dimitriou E. Engefalos. 1986, 23, 41–54.

Melzack R. The short-form McGill Pain Questionnaire. Pain. 1975;1(3), 277-299. DOI:10.1016/0304-3959(75)90044-5.

Horváth B, Janse IC, Blok JL et al. Hurley staging refined: a proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017; 97(3):412-413. DOI: 10.2340/00015555-2513.

Zouboulis CC, Tzellos T, Kyrgidis A, et al. European Hidradenitis Suppurativa Foundation Investigator Group Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017; 177(5), 1401-1409. DOI: 10.1111/bjd.15748.

Carniciu S, Hafi B, Gkini MA, Tzellos T, Jafferany M, Stamu‐O'Brien C. Secondary psychiatric disorders and the skin. Dermatological Reviews. 2023 :4(4), 162-171. DOI: 10.1002/der2.211.

Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011; 91(3), 328-332. DOI:10.2340/00015555-1082.

Onderdijk A J, Van der Zee HH, Esmann S et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013; 27(4): 473-478. DOI:10.1111/j.1468-3083.2012.04468.x.

Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2), 371-376. DOI:10.1111/jdv.12567.

Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen, K. Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study. J Invest Dermatology. 2018;138(1), 46-51. DOI:10.1016/j.jid.2017.06.020.

Rymaszewska J, Krajewski P, Szczęch J, Szepietowski J. Depression and anxiety in hidradenitis suppurativa patients: A cross-sectional study among Polish patients. Postępy Dermatol Alergol. 2022; 39(1). DOI:10.5114/ada.2022.119080.

Wolk K, Join‐Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):999-1010. DOI:10.1111/bjd.19556.

Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18. Published 2020 Mar 12. DOI:10.1038/s41572-020-0149-1.

Kouris A, Platsidaki E, Christodoulou C, et al. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. Dermatology. 2016;232(6):687-691. doi:10.1159/00045335.

Gooderham M, Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5), S19-S22. DOI:10.1016/j.jaad.2015.07.054.

Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry in Clinical Practice. 2005; 9(3), 187-192. DOI:10.1080/13651500510029129.

Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71(6), 1144-1150. DOI:10.1016/j.jaad.2014.09.012.

Saunte DM, Boer J, Stratigos A. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015 Dec;173(6):1546-9. doi: 10.1111/bjd.14038. Epub 2015 Nov 3.

Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014; 90(1062), 216-221. DOI:10.1136/postgradmedj-2013-131994.

Downloads

Published

2025-01-29

How to Cite

1.
Kontoangelos K, Foulou FD, Tsiori S, Papageorgiou C, Stratigos A, Liakou AI. Correlation Of Psychosomatic Factors And Personality Traits With The Severity Of Hidradenitis Suppurativa. Dermatol Pract Concept. 2025;15(1):4566. doi:10.5826/dpc.1501a4566

Share